Inventor · disambiguated record
Aleksandr V. Yurkovetskiy
Also filed as: YURKOVETSKIY ALEKSANDR · YURKOVETSKIY ALEKSANDR V
31 granted patents·19 pending applications·455 citations·filing 2008–2024
97Inventor score
Files withMERSANA THERAPEUTICS INC40ASANA BIOSCIENCES LLC4AKULLIAN LAURA C2YURKOVETSKIY ALEKSANDR2AKULLIAN LAURA1
Top patents by PatentIndex Score
50 records- 0198US8815226B2Protein-polymer-drug conjugatesMERSANA THERAPEUTICS INC·Filed 2012·Granted Aug 26, 2014·54 cites·8 claims
- 0297US9144615B2Protein-polymer-drug conjugatesMERSANA THERAPEUTICS INC·Filed 2014·Granted Sep 29, 2015·19 cites·22 claims
- 0397US8821850B2Protein-polymer-drug conjugatesMERSANA THERAPEUTICS INC·Filed 2014·Granted Sep 2, 2014·20 cites·18 claims
- 0496US9738720B2Monoclonal antibodies against HER2 epitope and methods of use thereofMERSANA THERAPEUTICS INC·Filed 2016·Granted Aug 22, 2017·10 cites·30 claims
- 0596US8349308B2Modified polymers for delivery of polynucleotides, method of manufacture, and methods of use thereofMERSANA THERAPEUTICS INC·Filed 2011·Granted Jan 8, 2013·141 cites·31 claims
- 0695US8808679B2Auristatin compounds and conjugates thereofMERSANA THERAPEUTICS INC·Filed 2013·Granted Aug 19, 2014·26 cites·20 claims
- 0795US8685383B2Protein-polymer-drug conjugatesYURKOVETSKIY ALEKSANDR·Filed 2012·Granted Apr 1, 2014·38 cites·9 claims
- 0894US10947317B2NaPi2b-targeted antibody-drug conjugates and methods of use thereofMERSANA THERAPEUTICS INC·Filed 2017·Granted Mar 16, 2021·9 cites·15 claims
- 0994US9555112B2Monoclonal antibodies against HER2 epitope and methods of use thereofMERSANA THERAPEUTICS INC·Filed 2015·Granted Jan 31, 2017·13 cites·42 claims
- 1093US10143695B2Pyrrolobenzodiazepines and conjugates thereofMERSANA THERAPEUTICS INC·Filed 2017·Granted Dec 4, 2018·7 cites·25 claims
- 1193US9254339B2Protein-polymer-drug conjugatesMERSANA THERAPEUTICS INC·Filed 2014·Granted Feb 9, 2016·16 cites·20 claims
- 1292US9770519B2Protein-polymer-drug conjugatesMERSANA THERAPEUTICS INC·Filed 2015·Granted Sep 26, 2017·2 cites·21 claims
- 1392US8399512B2Biocompatible biodegradable fumagillin analog conjugatesAKULLIAN LAURA C·Filed 2008·Granted Mar 19, 2013·37 cites·50 claims
- 1491US8524214B2Polyal drug conjugates comprising variable rate-releasing linkersYURKOVETSKIY ALEKSANDR·Filed 2010·Granted Sep 3, 2013·33 cites·30 claims
- 1589US11135307B2Peptide-containing linkers for antibody-drug conjugatesMERSANA THERAPEUTICS INC·Filed 2017·Granted Oct 5, 2021·4 cites·8 claims
- 1689US2025066489A1Monoclonal antibodies against her2 epitope and methods of use thereofMERSANA THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 1786US10660901B2Pyrrolobenzodiazepines and conjugates thereofMERSANA THERAPEUTICS INC·Filed 2018·Granted May 26, 2020·2 cites·25 claims
- 1885US10603386B2Protein-polymer-drug conjugatesMERSANA THERAPEUTICS INC·Filed 2017·Granted Mar 31, 2020·1 cites·18 claims
- 1984US11434278B2Protein-polymer-drug conjugatesASANA BIOSCIENCES LLC·Filed 2019·Granted Sep 6, 2022·1 cites·4 claims
- 2083US10526294B2Pyrrolobenzodiazepines and conjugates thereofMERSANA THERAPEUTICS INC·Filed 2017·Granted Jan 7, 2020·5 cites·29 claims
- 2182US10316080B2Protein-polymer-drug conjugatesASANA BIOSCIENCES LLC·Filed 2014·Granted Jun 11, 2019·4 cites·4 claims
- 2282US2023265197A1Monoclonal antibodies against her2 epitope and methods of use thereofMERSANA THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 2381US9872918B2Hydroxyl-polymer-drug-protein conjugatesMERSANA THERAPEUTICS INC·Filed 2013·Granted Jan 23, 2018·2 cites·14 claims
- 2480US9808528B2Protein-polymer-drug conjugates and methods of using sameMERSANA THERAPEUTICS INC·Filed 2015·Granted Nov 7, 2017·2 cites·20 claims
- 2579US9943609B2Protein-polymer-drug conjugatesMERSANA THERAPEUTICS INC·Filed 2016·Granted Apr 17, 2018·2 cites·20 claims
- 2678US9849191B2Protein-polymer-drug conjugatesMERSANA THERAPEUTICS INC·Filed 2014·Granted Dec 26, 2017·3 cites·19 claims
- 2778US2024382611A1Peptide-containing linkers for antibody-drug conjugatesMERSANA THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 2877US10226535B2Auristatin compounds and conjugates thereofMERSANA THERAPEUTICS INC·Filed 2013·Granted Mar 12, 2019·2 cites·19 claims
- 2974US11518812B2Monoclonal antibodies against HER2 epitope and methods of use thereofMERSANA THERAPEUTICS INC·Filed 2019·Granted Dec 6, 2022·0 cites·14 claims
- 3074US10772971B2Methods of producing drug-carrying polymer scaffolds and protein-polymer-drug conjugatesMERSANA THERAPEUTICS INC·Filed 2018·Granted Sep 15, 2020·1 cites·41 claims
- 3174US2023183326A1Protein-polymer-drug conjugatesASANA BIOSCIENCES LLC·Filed 2022·Application pending·0 cites
- 3271US2021106690A1Protein-polymer-drug conjugatesMERSANA THERAPEUTICS INC·Filed 2020·Application pending·0 cites
- 3369US11964025B2Peptide-containing linkers for antibody-drug conjugatesMERSANA THERAPEUTICS INC·Filed 2021·Granted Apr 23, 2024·0 cites·16 claims
- 3469US2017313778A1Monoclonal antibodies against her2 epitope and methods of use thereofMERSANA THERAPEUTICS INC·Filed 2017·Application pending·0 cites
- 3564US10537645B2Protein-polymer-drug conjugatesMERSANA THERAPEUTICS INC·Filed 2018·Granted Jan 21, 2020·0 cites·20 claims
- 3664US8491880B2Pharmaceutical formulations of biodegradable biocompatible camptothecin-polymer conjugatesROLKE JAMES·Filed 2009·Granted Jul 23, 2013·1 cites·93 claims
- 3763US2016022829A1Tubulysin compounds and conjugates thereofMERSANA THERAPEUTICS INC·Filed 2014·Application pending·0 cites
- 3861US2021301031A1Napi2b-targeted antibody-drug conjugates and methods of use thereofMERSANA THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 3961US2024082417A1Protein-polymer drug conjugatesASANA BIOSCIENCES LLC·Filed 2022·Application pending·0 cites
- 4059US2014017265A1Terminally Modified Polymers and Conjugates ThereofMERSANA THERAPEUTICS INC·Filed 2013·Application pending·0 cites
- 4158US2018243427A1Tubulysin compounds and conjugates thereofMERSANA THERAPEUTICS INC·Filed 2017·Application pending·0 cites
- 4253US2017119896A1Terminally modified polymers and conjugates thereofMERSANA THERAPEUTICS INC·Filed 2016·Application pending·0 cites
- 4352US2013158046A1Biocompatible biodegradable fumagillin analog conjugatesAKULLIAN LAURA C·Filed 2013·Application pending·0 cites
- 4450US11638760B2Pyrrolobenzodiazepine antibody conjugatesMERSANA THERAPEUTICS INC·Filed 2018·Granted May 2, 2023·0 cites·21 claims
- 4549US2022305127A1Pyrrolobenzodiazepine antibody conjugatesMERSANA THERAPEUTICS INC·Filed 2018·Application pending·0 cites
- 4648US2018140716A1Protein-polymer-drug conjugatesMERSANA THERAPEUTICS INC·Filed 2017·Application pending·0 cites
- 4748US2013109817A1Modified Polymers for Delivery of Polynucleotides, Method of Manufacture, and Methods of Use ThereofMERSANA THERAPEUTICS INC·Filed 2013·Application pending·0 cites
- 4847US2014004074A1Pharmaceutical Formulations of Biodegradable Biocompatible Camptothecin-Polymer ConjugatesMERSANA THERAPEUTICS INC·Filed 2013·Application pending·0 cites
- 4939US2018271996A1Combination therapies of her2-targeted antibody-drug conjugatesMERSANA THERAPEUTICS INC·Filed 2018·Application pending·0 cites
- 5037US2013189218A1Pharmaceutical formulations for fumagillin derivative-phf conjugatesAKULLIAN LAURA·Filed 2012·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →